Verve Therapeutics Inc (VERV)

Apr 16, 2025, 10:56 AM EDT - 7 days ago

Verve Therapeutics: FDA Fast Track And Eli Lilly Partnership Upgrade It To A 'Buy'

LLY

Apr 14, 2025, 11:34 AM EDT - 9 days ago

Verve Therapeutics Touts Positive Data From Gene Editing Medicine To Lower Cholesterol After Single Dose

Apr 14, 2025, 7:00 AM EDT - 10 days ago

Verve Therapeutics Announces Positive Initial Data from the Heart-2 Phase 1b Clinical Trial of VERVE-102, an In Vivo Base Editing Medicine Targeting PCSK9

Apr 11, 2025, 7:00 AM EDT - 13 days ago

Verve Therapeutics Receives U.S. FDA Fast Track Designation for VERVE-102, an In Vivo Base Editing Medicine Targeting PCSK9

Apr 4, 2025, 4:05 PM EDT - 19 days ago

Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Mar 24, 2025, 7:00 AM EDT - 4 weeks ago

Verve Therapeutics Announces Clearance of Investigational New Drug Application by the U.S. FDA for VERVE-102, an Investigational Gene Editing Medicine Designed to Durably Lower Cholesterol After a Single Dose

Feb 27, 2025, 7:00 AM EST - 2 months ago

Verve Therapeutics Announces Pipeline Progress and Reports Fourth Quarter and Full Year 2024 Financial Results

Jan 31, 2025, 11:11 AM EST - 2 months ago

Kuehn Law Encourages Investors of Verve Therapeutics, Inc. to Contact Law Firm

Jan 29, 2025, 7:00 AM EST - 3 months ago

Verve Therapeutics to Participate in the Guggenheim Securities SMID Cap Biotech Conference

Jan 26, 2025, 10:00 AM EST - 3 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Verve Therapeutics, Inc. (VERV) and Encourages Shareholders to Learn More About the Investigation

Jan 22, 2025, 10:00 AM EST - 3 months ago

Verve Therapeutics, Inc. (VERV) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation

Jan 19, 2025, 10:00 AM EST - 3 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages Verve Therapeutics, Inc. (VERV) Shareholders to Inquire about Securities Investigation

Jan 15, 2025, 10:00 AM EST - 3 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Verve Therapeutics, Inc. (VERV) And Encourages Shareholders to Connect

Jan 12, 2025, 10:00 AM EST - 3 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages Verve Therapeutics, Inc. (VERV) Stockholders to Inquire about Securities Investigation

Jan 8, 2025, 10:00 AM EST - 3 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Verve Therapeutics, Inc. (VERV) and Encourages Investors to Learn More About the Investigation

Jan 5, 2025, 10:00 AM EST - 3 months ago

Verve Therapeutics, Inc. (VERV) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

Jan 2, 2025, 10:00 AM EST - 3 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Verve Therapeutics, Inc. (VERV) And Encourages Investors to Connect

Dec 29, 2024, 10:00 AM EST - 4 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Verve Therapeutics, Inc. (VERV) And Encourages Stockholders to Connect

Dec 26, 2024, 10:00 AM EST - 4 months ago

Verve Therapeutics, Inc. (VERV) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation

Dec 22, 2024, 10:00 AM EST - 4 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Verve Therapeutics, Inc. (VERV) and Encourages Stockholders to Learn More About the Investigation

Dec 18, 2024, 10:00 AM EST - 4 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages Verve Therapeutics, Inc. (VERV) Investors to Inquire about Securities Investigation

Dec 15, 2024, 10:00 AM EST - 4 months ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Verve Therapeutics, Inc. (VERV) And Encourages Investors to Reach Out

Oct 27, 2024, 11:00 AM EDT - 6 months ago

DEADLINE APPROACHING: Verve Therapeutics Inc Is Being Sued For Violating Securities Laws And Affected Shareholders Are Urged To Contact The Schall Law Firm

Oct 25, 2024, 11:00 AM EDT - 6 months ago

Verve Therapeutics Inc Is Being Sued For Violating Securities Laws And Shareholders With Losses Are Urged To Contact The Schall Law Firm

Oct 22, 2024, 6:05 PM EDT - 6 months ago

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Verve Therapeutics

Oct 19, 2024, 11:00 AM EDT - 6 months ago

Verve Therapeutics Inc Is Being Sued For Violating Securities Laws And Affected Stockholders Are Urged To Reach Out To The Schall Law Firm

Oct 17, 2024, 11:00 AM EDT - 6 months ago

Verve Therapeutics Inc Is Being Sued For Violating Securities Laws And Affected Shareholders Are Urged To Contact The Schall Law Firm

Oct 15, 2024, 11:00 AM EDT - 6 months ago

Verve Therapeutics Inc Is Being Sued For Violating Securities Laws And Impacted Stockholders Are Urged To Help The Schall Law Firm

Oct 13, 2024, 11:00 AM EDT - 6 months ago

Verve Therapeutics Inc Is Being Sued For Violating Securities Laws And Affected Shareholders Are Urged To Reach Out To The Schall Law Firm

Oct 11, 2024, 11:00 AM EDT - 6 months ago

Verve Therapeutics Inc Is Being Sued For Violating Securities Laws And Impacted Shareholders Are Urged To Contact The Schall Law Firm

Oct 9, 2024, 11:00 AM EDT - 7 months ago

Verve Therapeutics Inc Is Being Sued For Violating Securities Laws And Impacted Shareholders Are Urged To Reach Out To The Schall Law Firm

Oct 4, 2024, 8:40 PM EDT - 7 months ago

VERV REMINDER – Robbins LLP Urges VERV Investors to Obtain Legal Counsel in Light of the Pending Lead Plaintiff Deadline